← Back to Search

MRI for Peritoneal Mesothelioma

N/A
Waitlist Available
Led By Hedy Kindler, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Biopsy-proven MPM
18 years old or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This trial is to test if new MRI and ultrasound techniques can detect cancer in the lining of the stomach better than current techniques.

Who is the study for?
This trial is for adults with biopsy-proven peritoneal mesothelioma who are planning surgery at UCM within 60 days. They must be able to undergo CT, MRI, and ultrasound scans as well as surgery. Women of childbearing age should commit to using contraception for a year after imaging.Check my eligibility
What is being tested?
Researchers are testing new experimental MRI and ultrasound techniques against standard CT imaging to see if they can better detect cancer spread in the stomach lining caused by mesothelioma.See study design
What are the potential side effects?
There may not be direct side effects from the imaging techniques themselves, but participants might experience discomfort or anxiety during long scanning sessions. Allergic reactions to contrast dyes used in these scans could also occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My diagnosis of mesothelioma was confirmed through a biopsy.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Higher Sensitivity for detection using New High Resolution Contrast Enhanced MRI Imaging Sequences compared to standard MRI
Higher sensitivity for detection of peritoneal metastatic disease using Ultrasound Elastography compared to standard MRI
Secondary outcome measures
Perform Ultrasound Elastography in peritoneal mesothelioma to determine elasticity scores
Perform Ultrasound Elastography in peritoneal mesothelioma to determine optimal strain ratios
Test high-definition small-voxel MRI imaging sequences for detection of peritoneal disease in MPM
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Testing Phase- Conventional and HR-MRI and UltrasoundExperimental Treatment2 Interventions
Patients will undergo conventional and HR-MRI imaging as well as abdominal ultrasound to define the performance of these methods.
Group II: Exploratory Phase - Standard CT Imaging and HR-MRIExperimental Treatment2 Interventions
The goal is to test several different novel Magnetic Resonance sequences to determine which gives the best visualization of peritoneal disease.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~1950

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,003 Previous Clinical Trials
819,723 Total Patients Enrolled
1 Trials studying Peritoneal Mesotheliomas
2 Patients Enrolled for Peritoneal Mesotheliomas
Hedy Kindler, MDPrincipal InvestigatorUniversity of Chicago
1 Previous Clinical Trials
15 Total Patients Enrolled
Kiran Turaga, MDPrincipal InvestigatorUniversity of Chicago
4 Previous Clinical Trials
395 Total Patients Enrolled
1 Trials studying Peritoneal Mesotheliomas
2 Patients Enrolled for Peritoneal Mesotheliomas

Media Library

Testing Phase- Conventional and HR-MRI and Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT03867578 — N/A
Peritoneal Mesotheliomas Research Study Groups: Testing Phase- Conventional and HR-MRI and Ultrasound, Exploratory Phase - Standard CT Imaging and HR-MRI
Peritoneal Mesotheliomas Clinical Trial 2023: Testing Phase- Conventional and HR-MRI and Ultrasound Highlights & Side Effects. Trial Name: NCT03867578 — N/A
Testing Phase- Conventional and HR-MRI and Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT03867578 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being allowed to take part in this trial?

"Affirmative. The records available on clinicaltrials.gov confirm that this medical research, which was initially posted in October 2018, is currently recruiting subjects. 24 participants will be admitted from a single study centre."

Answered by AI

What goals are researchers attempting to accomplish with this clinical experiment?

"This 60-day trial aims to improve sensitivity of diagnosis using high resolution contrast enhanced MRI imaging sequences. Additionally, it will assess ultrasound elastography in order to ascertain optimal strain ratios and elasticity scores that can optimise accuracy for peritoneal mesothelioma patients. Finally, the experiment would test HD small-voxel MRIs focusing on right hemidiaphragmatic and pelvic spaces to detect malignant disease."

Answered by AI

Is it still feasible to join this experimental endeavor?

"Affirmative, the information hosted by clinicaltrials.gov specifies that this trial is presently in search of candidates. This study was first denoted on October 10th 2018 and last modified on May 16th 2022; 24 patients are desired for enrollment at a single site."

Answered by AI
~4 spots leftby Apr 2025